Biotech Archives - Page 689 of 733

1 minute read

Cassava Insiders Got A Lot Richer As Shares Rebound Following Refutation of Data Manipulation Claims

August 18, 1:06 PM

Journal of Prevention of Alzheimer’s Disease (JPAD) informed Cassava Sciences Inc (NASDAQ:SAVA) about no convincing evidence to support data manipulation allegations…

SAVA

1 minute read

Novavax’s Covid-19 Vaccine Cleared For Use In New Zealanders Aged 12-17

By Vandana Singh

August 18, 12:18 PM

New Zealand’s Medsafe has granted expanded provisional approval for Novavax Inc’s (NASDAQ:NVAX) Nuvaxovid (NVX-CoV2373) COVID-19 vaccine in adolescents aged 12 through 17.…

NVAX

1 minute read

Fighting Omicron: This Covid Vaccine Candidate Is Going After The Dangerous Mutation

By Vandana Singh

August 18, 12:12 PM

CureVac N.V. (NASDAQ:CVAC) and GSK plc (NYSE:GSK) have started a Phase 1 trial of the modified COVID-19 mRNA vaccine candidate, administered as a…

CVAC

1 minute read

China-Based Jemincare Inks Prostate Cancer Drug Pact With Roche’s Genentech

By Vandana Singh

August 18, 12:07 PM

After penning a deal with Orion in May for a non-opioid pain drug, Jemincare is back at the…

RHHBF

1 minute read

Astellas’ Menopause Drug Under FDA Review

By Vandana Singh

August 18, 12:04 PM

The FDA accepted Astellas Pharma Inc’s (OTC:ALPMF) menopause treatment for approval five months after the therapy hit a speed bump in…

ALPMF

1 minute read

Arcturus’ COVID-19 Booster Shows Durability Against Omicron Variants

By Vandana Singh

August 18, 12:00 PM

Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) announced updated data from its ongoing ARCT-154 booster clinical trial. The new results demonstrate a broad…

ARCT

1 minute read

89bio Shares Climb After Concluding Enrolment In Mid-Stage NASH Study

By Ragothaman Srinivasan

August 18, 11:18 AM

89bio (NASDAQ: ETNB) has completed enrollment in ENLIVEN, the Phase 2b trial of pegozafermin for the treatment of non-alcoholic steatohepatitis (NASH).

ETNB

1 minute read

BridgeBio Starts Dosing In Early-Stage Genetic Metabolism Disorder Trial

By Vandana Singh

August 18, 8:53 AM

BridgeBio Pharma Inc (NASDAQ:BBIO) has dosed the first patient in its Phase 1 trial of BBP-671, an investigational oral therapy for…

BBIO

1 minute read

FDA Clears Curis’ Lymphoma Study, Keeping Leukemia Trial Still Stalled

By Vandana Singh

August 18, 8:49 AM

The FDA has lifted the partial clinical hold on Curis Inc’s (NASDAQ:CRIS) TakeAim Lymphoma Phase 1/2 study of emavusertib after reviewing the…

CRIS

1 minute read

ABVC BioPharma Says Phase II Vitargus Clinical Trial Receives Local Ethics Committee Approval In Thailand

By Benzinga Newsdesk

August 18, 8:33 AM

ABVC BioPharma, Inc. (NASDAQ:ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that, on August 2, 2022, approval was

ABVC